1. Benton SC, Tetteh GK, Needham SJ, Mücke J, Sheppard L, Alderson S, et al. 2020; Evaluation of the 25-hydroxy vitamin D assay on a fully automated liquid chromatography mass spectrometry system, the Thermo Scientific Cascadion SM Clinical Analyzer with the Cascadion 25-hydroxy vitamin D assay in a routine clinical laboratory. Clin Chem Lab Med. 58:1010–7. DOI:
10.1515/cclm-2019-0834. PMID:
31851610.
2. Metz TF, Mechtler TP, Merk M, Gottschalk A, Lukačin R, Herkner KR, et al. 2012; Evaluation of a novel, commercially available mass spectrometry kit for newborn screening including succinylacetone without hydrazine. Clin Chim Acta. 413:1259–64. DOI:
10.1016/j.cca.2012.04.007. PMID:
22521492.
3. Polledri E, Mercadante R, Ferraris Fusarini C, Maiavacca R, Fustinoni S. 2017; Immunosuppressive drugs in whole blood: validation of a commercially available liquid chromatography/tandem mass spectrometry kit and comparison with immunochemical assays. Rapid Commun Mass Spectrom. 31:1111–20. DOI:
10.1002/rcm.7887. PMID:
28439923.
4. Duncan MW, Nedelkov D, Walsh R, Hattan SJ. 2016; Applications of MALDI mass spectrometry in clinical chemistry. Clin Chem. 62:134–43. DOI:
10.1373/clinchem.2015.239491. PMID:
26585930.
5. Croxatto A, Prod'hom G, Greub G. 2012; Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology. FEMS Microbiol Rev. 36:380–407. DOI:
10.1111/j.1574-6976.2011.00298.x. PMID:
22092265.
6. Millington DS, Norwood DL, Kodo N, Roe CR, Inoue F. 1989; Application of fast atom bombardment with tandem mass spectrometry and liquid chromatography/mass spectrometry to the analysis of acylcarnitines in human urine, blood, and tissue. Anal Biochem. 180:331–9. DOI:
10.1016/0003-2697(89)90441-7. PMID:
2817363.
7. Jones PM, Bennett MJ. 2010; Urine organic acid analysis for inherited metabolic disease using gas chromatography-mass spectrometry. In: Garg U., Hammett-Stabler C. (eds) Clinical Applications of Mass Spectrometry. Methods in Molecular Biology (Methods and Protocols), vol 603. Humana Press,. 423–31. DOI:
10.1007/978-1-60761-459-3_41. PMID:
20077094.
8. Singh RJ, Grebe SK, Yue B, Rockwood AL, Cramer JC, Gombos Z, et al. 2005; Precisely wrong? Urinary fractionated metanephrines and peer-based laboratory proficiency testing. Clin Chem. 51:472–3. discussion 473–4. DOI:
10.1373/clinchem.2004.043802. PMID:
15681566.
9. Hanari N, Itoh N, Ishikawa K, Yarita T, Numata M. 2014; Variation in concentration of perfluorooctanoic acid in methanol solutions during storage. Chemosphere. 94:116–20. DOI:
10.1016/j.chemosphere.2013.09.040. PMID:
24139159.
11. Choi K. 2020; Purity assessment using quantitative NMR: establishment of SI traceability in organic analysis. J Korean Magn Reson Soc. 24:30–7.
14. Shuford CM, Walters JJ, Holland PM, Sreenivasan U, Askari N, Ray K, et al. 2017; Absolute protein quantification by mass spectrometry: not as simple as advertised. Anal Chem. 89:7406–15. DOI:
10.1021/acs.analchem.7b00858. PMID:
28605192.
15. Leinenbach A, Pannee J, Dülffer T, Huber A, Bittner T, Andreasson U, et al. 2014; Mass spectrometry-based candidate reference measurement procedure for quantification of amyloid-β in cerebrospinal fluid. Clin Chem. 60:987–94. DOI:
10.1373/clinchem.2013.220392. PMID:
24842955.
16. Tai SS, Welch MJ. 2005; Development and evaluation of a reference measurement procedure for the determination of estradiol-17β in human serum using isotope-dilution liquid chromatography-tandem mass spectrometry. Anal Chem. 77:6359–63. DOI:
10.1021/ac050837i. PMID:
16194100.
17. Tai SS, Welch MJ. 2004; Development and evaluation of a candidate reference method for the determination of total cortisol in human serum using isotope dilution liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry. Anal Chem. 76:1008–14. DOI:
10.1021/ac034966f. PMID:
14961732.
18. Lindegardh N, Annerberg A, White NJ, Day NP. 2008; Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of piperaquine in plasma: stable isotope labeled internal standard does not always compensate for matrix effects. J Chromatogr B Analyt Technol Biomed Life Sci. 862:227–36. DOI:
10.1016/j.jchromb.2007.12.011. PMID:
18191623.
19. Berg T, Strand DH. 2011; 13C labelled internal standards-a solution to minimize ion suppression effects in liquid chromatography-tandem mass spectrometry analyses of drugs in biological samples? J Chromatogr A. 1218:9366–74. DOI:
10.1016/j.chroma.2011.10.081. PMID:
22119139.
20. Davison AS, Milan AM, Dutton JJ. 2013; Potential problems with using deuterated internal standards for liquid chromatography-tandem mass spectrometry. Ann Clin Biochem. 50:274. DOI:
10.1177/0004563213478938. PMID:
23605130.
22. Liigand J, Laaniste A, Kruve A. 2017; pH effects on electrospray ionization efficiency. J Am Soc Mass Spectrom. 28:461–9. DOI:
10.1007/s13361-016-1563-1. PMID:
27966175.
23. Rauha JP, Vuorela H, Kostiainen R. 2001; Effect of eluent on the ionization efficiency of flavonoids by ion spray, atmospheric pressure chemical ionization, and atmospheric pressure photoionization mass spectrometry. J Mass Spectrom. 36:1269–80. DOI:
10.1002/jms.231. PMID:
11754118.
24. Deventer K, Pozo OJ, van Eenoo P, Delbeke FT. 2009; Development and validation of an LC-MS/MS method for the quantification of ephedrines in urine. J Chromatogr B Analyt Technol Biomed Life Sci. 877:369–74. DOI:
10.1016/j.jchromb.2008.12.032. PMID:
19144576.
25. Eyles D, Anderson C, Ko P, Jones A, Thomas A, Burne T, et al. 2009; A sensitive LC/MS/MS assay of 25OH vitamin D3 and 25OH vitamin D2 in dried blood spots. Clin Chim Acta. 403:145–51. DOI:
10.1016/j.cca.2009.02.005. PMID:
19232332.
26. Ferreiro-Vera C, Ribeiro JP, Mata-Granados JM, Priego-Capote F, Luque de Castro MD. 2011; Standard operation protocol for analysis of lipid hydroperoxides in human serum using a fully automated method based on solid-phase extraction and liquid chromatography-mass spectrometry in selected reaction monitoring. J Chromatogr A. 1218:6720–6. DOI:
10.1016/j.chroma.2011.07.080. PMID:
21851945.
27. Kuhn J, Götting C, Kleesiek K. 2010; Sample cleanup-free determination of mycophenolic acid and its glucuronide in serum and plasma using the novel technology of ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry. Talanta. 80:1894–8. DOI:
10.1016/j.talanta.2009.10.040. PMID:
20152429.
28. Bittersohl H, Schniedewind B, Christians U, Luppa PB. 2018; A simple and highly sensitive on-line column extraction liquid chromatography-tandem mass spectrometry method for the determination of protein-unbound tacrolimus in human plasma samples. J Chromatogr A. 1547:45–52. DOI:
10.1016/j.chroma.2018.03.010. PMID:
29544893.
30. Bunch DR, McShane AJ, Wang S. 2018; Investigation of transition ion ratio variation for liquid chromatography-tandem mass spectrometry: a case study approach. Clin Chim Acta. 486:205–8. DOI:
10.1016/j.cca.2018.08.009. PMID:
30098951.
31. Kushnir MM, Rockwood AL, Nelson GJ, Yue B, Urry FM. 2005; Assessing analytical specificity in quantitative analysis using tandem mass spectrometry. Clin Biochem. 38:319–27. DOI:
10.1016/j.clinbiochem.2004.12.003. PMID:
15766733.
32. Rappold BA. Transition ratios for the product-ion-poor: activation energy modulation in the absence of distinct neutral losses. In : Presented at ASMS 2019; Atlanta. p. Poster TP 102.
33. Scherer M, Gnewuch C, Schmitz G, Liebisch G. 2009; Rapid quantification of bile acids and their conjugates in serum by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 877:3920–5. DOI:
10.1016/j.jchromb.2009.09.038. PMID:
19819765.
34. , et al. Anderson JL, Berthod A, Pino V, Stallcup AM, editors. Peris‐Vicente J. Esteve‐Romero J. 2015. Validation of analytical methods based on chromatographic techniques: an overview. Analytical Separation Science. Wiley;Hoboken: p. 1757–808. DOI:
10.1002/9783527678129.assep064.
35. Hewitt EF, Lukulay P, Galushko S. 2006; Implementation of a rapid and automated high performance liquid chromatography method development strategy for pharmaceutical drug candidates. J Chromatogr A. 1107:79–87. DOI:
10.1016/j.chroma.2005.12.042. PMID:
16406385.
36. Dong MW, Zhang K. 2014; Ultra-high-pressure liquid chromatography (UHPLC) in method development. TrAC Trends Anal Chem. 63:21–30. DOI:
10.1016/j.trac.2014.06.019.
37. Debrus B, Guillarme D, Rudaz S. 2013; Improved quality-by-design compliant methodology for method development in reversed-phase liquid chromatography. J Pharm Biomed Anal. 84:215–23. DOI:
10.1016/j.jpba.2013.06.013. PMID:
23850937.
38. He X, Kozak M, Nimkar S. 2012; Ultra-sensitive measurements of 11-Nor-δ(9)-tetrahydrocannabinol-9-carboxylic acid in oral fluid by microflow liquid chromatography-tandem mass spectrometry using a benchtop quadrupole/orbitrap mass spectrometer. Anal Chem. 84:7643–7. DOI:
10.1021/ac3019476. PMID:
22900543.
39. Christianson CC, Johnson CJ, Needham SR. 2013; The advantages of microflow LC-MS/MS compared with conventional HPLC-MS/MS for the analysis of methotrexate from human plasma. Bioanalysis. 5:1387–96. DOI:
10.4155/bio.13.73. PMID:
23742308.
40. Remane D, Wissenbach DK, Peters FT. 2016; Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology-an update. Clin Biochem. 49:1051–71. DOI:
10.1016/j.clinbiochem.2016.07.010. PMID:
27452180.
41. Reising AE, Godinho JM, Hormann K, Jorgenson JW, Tallarek U. 2016; Larger voids in mechanically stable, loose packings of 1.3 μm frictional, cohesive particles: their reconstruction, statistical analysis, and impact on separation efficiency. J Chromatogr A. 1436:118–32. DOI:
10.1016/j.chroma.2016.01.068. PMID:
26858113.
42. Stanley BJ, Foster CR, Guiochon G. 1997; On the reproducibility of column performance in liquid chromatography and the role of the packing density. J Chromatogr A. 761:41–51. DOI:
10.1016/S0021-9673(96)00804-7.
43. Schwope DM, Scheidweiler KB, Huestis MA. 2011; Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 401:1273–83. DOI:
10.1007/s00216-011-5197-7. PMID:
21727996. PMCID:
PMC3159033.
44. Saba A, Donzelli R, Colligiani D, Raffaelli A, Nannipieri M, Kusmic C, et al. 2014; Quantification of thyroxine and 3,5,3′-triiodo-thyronine in human and animal hearts by a novel liquid chromatography-tandem mass spectrometry method. Horm Metab Res. 46:628–34. DOI:
10.1055/s-0034-1368717. PMID:
24591048.
45. Yoo IY, Lee K, Ji OJ, Woo HI, Lee SY. 2018; Evaluation of stability of thiopurine metabolites using a validated LC-MS/MS method. Ann Lab Med. 38:255–60. DOI:
10.3343/alm.2018.38.3.255. PMID:
29401561. PMCID:
PMC5820071.
46. Lee SM, Lee MN, Oh HJ, Cho YY, Kim JH, Woo HI, et al. 2015; Development and validation of liquid chromatography-tandem mass spectrometry method for quantification of plasma metanephrines for differential diagnosis of adrenal incidentaloma. Ann Lab Med. 35:519–22. DOI:
10.3343/alm.2015.35.5.519. PMID:
26206689. PMCID:
PMC4510505.
47. Vogeser M, Kyriatsoulis A, Huber E, Kobold U. 2004; Candidate reference method for the quantification of circulating 25-hydroxyvitamin D3 by liquid chromatography-tandem mass spectrometry. Clin Chem. 50:1415–7. DOI:
10.1373/clinchem.2004.031831. PMID:
15277348.
48. Kushnir MM, Blamires T, Rockwood AL, Roberts WL, Yue B, Erdogan E, et al. 2010; Liquid chromatography-tandem mass spectrometry assay for androstenedione, dehydroepiandrosterone, and testosterone with pediatric and adult reference intervals. Clin Chem. 56:1138–47. DOI:
10.1373/clinchem.2010.143222. PMID:
20489135.
49. Kim H, Sohn A, Yeo I, Yu SJ, Yoon JH, Kim Y. 2018; Clinical assay for AFP-L3 by using multiple reaction monitoring-mass spectrometry for diagnosing hepatocellular carcinoma. Clin Chem. 64:1230–8. DOI:
10.1373/clinchem.2018.289702. PMID:
29875214.
50. van den Ouweland JM, Beijers AM, Demacker PN, van Daal H. 2010; Measurement of 25-OH-vitamin D in human serum using liquid chromatography tandem-mass spectrometry with comparison to radioimmunoassay and automated immunoassay. J Chromatogr B Analyt Technol Biomed Life Sci. 878:1163–8. DOI:
10.1016/j.jchromb.2010.03.035. PMID:
20381436.
51. Lakso HA, Appelblad P, Schneede J. 2008; Quantification of methylmalonic acid in human plasma with hydrophilic interaction liquid chromatography separation and mass spectrometric detection. Clin Chem. 54:2028–35. DOI:
10.1373/clinchem.2007.101253. PMID:
18845771.
52. Oßwald A, Wang R, Beuschlein F, Hartmann MF, Wudy SA, Bidlingmaier M, et al. 2019; Performance of LC-MS/MS and immunoassay based 24-h urine free cortisol in the diagnosis of Cushing's syndrome. J Steroid Biochem Mol Biol. 190:193–7. DOI:
10.1016/j.jsbmb.2019.04.004. PMID:
30959155.
53. Keevil BG, MacDonald P, Macdowall W, Lee DM, Wu FC. NATSAL Team. 2014; Salivary testosterone measurement by liquid chromatography tandem mass spectrometry in adult males and females. Ann Clin Biochem. 51:368–78. DOI:
10.1177/0004563213506412. PMID:
24194586. PMCID:
PMC5029560.
54. Lenk A. 2018; Solvents: an overlooked ally for liquid chromatography-mass spectrometry. The Column. 14:19–21.
55. Rebane R, Kruve A, Liigand J, Liigand P, Gornischeff A, Leito I. 2019; Ionization efficiency ladders as tools for choosing ionization mode and solvent in liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom. 33:1834–43. DOI:
10.1002/rcm.8545. PMID:
31381213.
56. Grant RP, Rappold BA. Rifai N, Horvath AR, Wittwer CT, Hoofnagle A, editors. 2018. Development and validation of small molecule analytes by liquid chromatography-tandem mass spectrometry. Principles and Applications of Clinical Mass Spectrometry: Small Molecules, Peptides, and Pathogens. Elsevier;Amsterdam: p. 115–79. DOI:
10.1016/B978-0-12-816063-3.00005-0.
57. Bennett PK, Van Horne KC. Identification of the major endogenous and persistent compounds in plasma, serum and tissue that cause matrix effects with electrospray LC/MS techniques. In : American Association of Pharmaceutical Scientists Conference; Oct 24-25 2003; Salt Lake City, Utah.
59. Little JL, Wempe MF, Buchanan CM. 2006; Liquid chromatography-mass spectrometry/mass spectrometry method development for drug metabolism studies: examining lipid matrix ionization effects in plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 833:219–30. DOI:
10.1016/j.jchromb.2006.02.011. PMID:
16497566.
60. Little JL, Williams AJ, Pshenichnov A, Tkachenko V. 2012; Identification of "known unknowns" utilizing accurate mass data and ChemSpider. J Am Soc Mass Spectrom. 23:179–85. DOI:
10.1007/s13361-011-0265-y. PMID:
22069037.
61. Rappold BA. 2018; Special considerations for liquid chromatography-tandem mass spectrometry method development. Clin Lab Med. 38:539–51. DOI:
10.1016/j.cll.2018.05.003. PMID:
30115397.
62. Clinical and Laboratory Standards Institute. 2018. Interference testing in Clin Chem; approved guideline. CLSI document EP7-A3. 3rd ed. Clinical and Laboratory Standards Institute;Wayne, PA:
63. Haidar Ahmad IA, Chen W, Halsey HM, Klapars A, Limanto J, Pirrone GF, et al. 2019; Multi-column ultra-high performance liquid chromatography screening with chaotropic agents and computer-assisted separation modeling enables process development of new drug substances. Analyst. 144:2872–80. DOI:
10.1039/C8AN02499E. PMID:
30830135.
64. Rappold BA, Grant RP. 2011; HILIC‐MS/MS method development for targeted quantitation of metabolites: practical considerations from a clinical diagnostic perspective. J Sep Sci. 34:3527–37. DOI:
10.1002/jssc.201100550. PMID:
22084005.
65. Hennion MC. 1999; Solid-phase extraction: method development, sorbents, and coupling with liquid chromatography. J Chromatogr A. 856:3–54. DOI:
10.1016/S0021-9673(99)00832-8. PMID:
10526783.
66. Buszewski B, Szultka M. 2012; Past, present, and future of solid phase extraction: a review. Crit Rev Anal Chem. 42:198–213. DOI:
10.1080/07373937.2011.645413.
67. Chambers E, Wagrowski-Diehl DM, Lu Z, Mazzeo JR. 2007; Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. J Chromatogr B Analyt Technol Biomed Life Sci. 852:22–34. DOI:
10.1016/j.jchromb.2006.12.030. PMID:
17236825.
68. Živanović L, Ličanski A, Zečević M, Jocić B, Kostić M. 2008; Application of experimental design in optimization of solid phase extraction of mycophenolic acid and mycophenolic acid glucuronide from human urine and plasma and SPE-RP-HPLC method validation. J Pharm Biomed Anal. 47:575–85. DOI:
10.1016/j.jpba.2008.01.046. PMID:
18356001.
69. Covaci A, Voorspoels S. 2005; Optimization of the determination of polybrominated diphenyl ethers in human serum using solid-phase extraction and gas chromatography-electron capture negative ionization mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 827:216–23. DOI:
10.1016/j.jchromb.2005.09.020. PMID:
16203180.
70. Yuan L, Aubry AF, Arnold ME, Ji QC. 2013; Systematic investigation of orthogonal SPE sample preparation for the LC-MS/MS bioanalysis of a monoclonal antibody after pellet digestion. Bioanalysis. 5:2379–91. DOI:
10.4155/bio.13.224. PMID:
24066623.
71. Nemeškalová A, Bursová M, Sýkora D, Kuchař M, Čabala R, Hložek T. 2019; Salting out assisted liquid-liquid extraction for liquid chromatography tandem-mass spectrometry determination of amphetamine-like stimulants in meconium. J Pharm Biomed Anal. 172:42–9. DOI:
10.1016/j.jpba.2019.04.036. PMID:
31022615.
72. Tang YQ, Weng N. 2013; Salting-out assisted liquid-liquid extraction for bioanalysis. Bioanalysis. 5:1583–98. DOI:
10.4155/bio.13.117. PMID:
23795935.
73. Rashidipour M, Heydari R, Maleki A, Mohammadi E, Davari B. 2019; Salt-assisted liquid-liquid extraction coupled with reversed-phase dispersive liquid-liquid microextraction for sensitive HPLC determination of paraquat in environmental and food samples. J Food Meas Char. 13:269–76. DOI:
10.1007/s11694-018-9941-y.
74. Tölgyesi Á, Barta E, Simon A, McDonald TJ, Sharma VK. 2017; Screening and confirmation of steroids and nitroimidazoles in urine, blood, and food matrices: sample preparation methods and liquid chromatography tandem mass spectrometric separations. J Pharm Biomed Anal. 145:805–13. DOI:
10.1016/j.jpba.2017.08.005. PMID:
28822347.
75. Meunier C, Blondelle D, Faure P, Baguet JP, Le Goff C, Chabre O, et al. 2015; Development and validation of a method using supported liquid extraction for aldosterone determination in human plasma by LC-MS/MS. Clin Chim Acta. 447:8–15. DOI:
10.1016/j.cca.2015.05.007. PMID:
25982778.
76. Jagerdeo E, Schaff JE. 2016; Rapid screening for drugs of abuse in biological fluids by ultra high performance liquid chromatography/orbitrap mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 1027:11–8. DOI:
10.1016/j.jchromb.2016.05.010. PMID:
27236533.
77. Dotsikas Y, Kousoulos C, Tsatsou G, Loukas YL. 2005; Development of a rapid method for the determination of glimepiride in human plasma using liquid‐liquid extraction based on 96‐well format micro‐tubes and liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 19:2055–61. DOI:
10.1002/rcm.2028. PMID:
15988714.
78. Tweed JA, Walton J, Gu Z. 2012; Automated supported liquid extraction using 2D barcode processing for routine toxicokinetic portfolio support. Bioanalysis. 4:249–62. DOI:
10.4155/bio.11.314. PMID:
22303829.
79. Khan A, Khan MI, Iqbal Z, Ahmad L, Shah Y, Watson DG. 2010; Determination of lipoic acid in human plasma by HPLC-ECD using liquid-liquid and solid-phase extraction: method development, validation and optimization of experimental parameters. J Chromatogr B Analyt Technol Biomed Life Sci. 878:2782–8. DOI:
10.1016/j.jchromb.2010.08.022. PMID:
20829127.
80. Halvorsen TG, Reubsaet L. 2017; Antibody based affinity capture LC-MS/MS in quantitative determination of proteins in biological matrices. TrAC Trends Anal Chem. 95:132–9. DOI:
10.1016/j.trac.2017.08.009.
81. Lowenthal MS, Gasca-Aragon H, Schiel JE, Dodder NG, Bunk DM. 2011; A quantitative LC-MS/MS method for comparative analysis of capture-antibody affinity toward protein antigens. J Chromatogr B Analyt Technol Biomed Life Sci. 879:2726–32. DOI:
10.1016/j.jchromb.2011.07.037. PMID:
21856254.
82. Lund H, Paus E, Berger P, Stenman UH, Torcellini T, Halvorsen TG, et al. 2014; Epitope analysis and detection of human chorionic gonadotropin (hCG) variants by monoclonal antibodies and mass spectrometry. Tumour Biol. 35:1013–22. DOI:
10.1007/s13277-013-1135-y. PMID:
24014048.
83. Becker JO, Hoofnagle AN. 2012; Replacing immunoassays with tryptic digestion-peptide immunoaffinity enrichment and LC-MS/MS. Bioanalysis. 4:281–90. DOI:
10.4155/bio.11.319. PMID:
22303832. PMCID:
PMC3699856.
84. van den Broek I, Smit NP, Romijn FP, van der Laarse A, Deelder AM, van der Burgt YE, et al. 2013; Evaluation of interspecimen trypsin digestion efficiency prior to multiple reaction monitoring-based absolute protein quantification with native protein calibrators. J Proteome Res. 12:5760–74. DOI:
10.1021/pr400763d. PMID:
24168082.
85. Neubert H, Shuford CM, Olah TV, Garofolo F, Schultz GA, Jones BR, et al. 2020; Protein biomarker quantification by immunoaffinity liquid chromatography-tandem mass spectrometry: current state and future vision. Clin Chem. 66:282–301. DOI:
10.1093/clinchem/hvz022. PMID:
32040572.
86. Cobbaert CM, Althaus H, Begcevic Brkovic I, Ceglarek U, Coassin S, Delatour V, et al. 2021; Towards an SI-traceable reference measurement system for seven serum apolipoproteins using bottom-up quantitative proteomics: conceptual approach enabled by cross-disciplinary/cross-sector collaboration. Clin Chem. 67:478–89. DOI:
10.1093/clinchem/hvaa239. PMID:
33331636.
87. Marcovina SM, Clouet-Foraison N, Koschinsky ML, Lowenthal MS, Orquillas A, Boffa MB, et al. 2021; Development of an LC-MS/MS proposed candidate reference method for the standardization of analytical methods to measure lipoprotein (a). Clin Chem. 67:490–9. DOI:
10.1093/clinchem/hvaa324. PMID:
33517366. PMCID:
PMC7935757.
88. Nielsen MK, Johansen SS. 2009; Determination of olanzapine in whole blood using simple protein precipitation and liquid chromatography-tandem mass spectrometry. J Anal Toxicol. 33:212–7. DOI:
10.1093/jat/33.4.212. PMID:
19470224.
89. Strathmann FG, Laha TJ, Hoofnagle AN. 2011; Quantification of 1α, 25-dihydroxy vitamin D by immunoextraction and liquid chromatography-tandem mass spectrometry. Clin Chem. 57:1279–85. DOI:
10.1373/clinchem.2010.161174. PMID:
21768219. PMCID:
PMC3261234.
90. Martens-Lobenhoffer J, Bode-Böger SM. 2006; Fast and efficient determination of arginine, symmetric dimethylarginine, and asymmetric dimethylarginine in biological fluids by hydrophilic-interaction liquid chromatography-electrospray tandem mass spectrometry. Clin Chem. 52:488–93. DOI:
10.1373/clinchem.2005.060152. PMID:
16384887.
91. Polson C, Sarkar P, Incledon B, Raguvaran V, Grant R. 2003; Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 785:263–75. DOI:
10.1016/S1570-0232(02)00914-5. PMID:
12554139.
92. Marney LC, Laha TJ, Baird GS, Rainey PM, Hoofnagle AN. 2008; Isopropanol protein precipitation for the analysis of plasma free metanephrines by liquid chromatography-tandem mass spectrometry. Clin Chem. 54:1729–32. DOI:
10.1373/clinchem.2008.104083. PMID:
18687739.
93. Gao H, Williams J, Carrier S, Brummel CL. 2010; Bioanalytical solutions to acetonitrile shortages. Bioanalysis. 2:1627–40. DOI:
10.4155/bio.10.76. PMID:
21083291.
94. Johnson DW. 2011; Free amino acid quantification by LC-MS/MS using derivatization generated isotope-labelled standards. J Chromatogr B Analyt Technol Biomed Life Sci. 879:1345–52. DOI:
10.1016/j.jchromb.2010.12.010. PMID:
21195681.
95. Higashi T, Shimada K. 2004; Derivatization of neutral steroids to enhance their detection characteristics in liquid chromatography-mass spectrometry. Anal Bioanal Chem. 378:875–82. DOI:
10.1007/s00216-003-2252-z. PMID:
14598004.
96. Phipps WS, Crossley E, Boriack R, Jones PM, Patel K. 2020; Quantitative amino acid analysis by liquid chromatography‐tandem mass spectrometry using low cost derivatization and an automated liquid handler. JIMD Rep. 51:62–9. DOI:
10.1002/jmd2.12080. PMID:
32071840. PMCID:
PMC7012744.
97. Aronov PA, Hall LM, Dettmer K, Stephensen CB, Hammock BD. 2008; Metabolic profiling of major vitamin D metabolites using Diels-Alder derivatization and ultra-performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 391:1917–30. DOI:
10.1007/s00216-008-2095-8. PMID:
18437365. PMCID:
PMC3587164.
98. Held PK, White L, Pasquali M. 2011; Quantitative urine amino acid analysis using liquid chromatography tandem mass spectrometry and aTRAQ® reagents. J Chromatogr B. 879:2695–703. DOI:
10.1016/j.jchromb.2011.07.030. PMID:
21852206.
99. CLSI. 2003. Evaluation of the linearity of quantitative measurement procedures: A statistical approach; approved Guideline. CLSI document EP6-A. Clinical and Laboratory Standards Institute;Wayne, PA:
100. Kushnir MM, Urry FM, Frank EL, Roberts WL, Shushan B. 2002; Analysis of catecholamines in urine by positive-ion electrospray tandem mass spectrometry. Clin Chem. 48:323–31. DOI:
10.1093/clinchem/48.2.323. PMID:
11805014.
101. Johansen SS, Bhatia HM. 2007; Quantitative analysis of cocaine and its metabolites in whole blood and urine by high-performance liquid chromatography coupled with tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 852:338–44. DOI:
10.1016/j.jchromb.2007.01.033. PMID:
17301000.
102. Carobene A, Ferrero C, Ceriotti F, Modenese A, Besozzi M, de Giorgi E, et al. 1997; Creatinine measurement proficiency testing: assignment of matrix-adjusted ID GC-MS target values. Clin Chem. 43:1342–7. DOI:
10.1093/clinchem/43.8.1342. PMID:
9267311.
103. Colletti JD, Redor-Goldman MM, Pomperada AE, Ghoshal AK, Wu WW, McPhaul MJ, et al. 2020; Sample multiplexing: increased throughput for quantification of total testosterone in serum by liquid chromatography-tandem mass spectrometry. Clin Chem. 66:1181–9. DOI:
10.1093/clinchem/hvaa117. PMID:
32870993.
104. Campbell MT, Cahill K, Rappold B. When matrix matched calibration systems don't match truth: distinguishing trueness from accuracy for THC-COOH in urine. In : Presented at ASMS 2019; Atlanta. p. Poster WP 174.
105. Kaufmann M, Gallagher JC, Peacock M, Schlingmann KP, Konrad M, DeLuca HF, et al. 2014; Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D and 24, 25-dihydroxyvitamin D by LC-MS/MS involving derivatization with DMEQ-TAD. J Clin Endocrinol Metab. 99:2567–74. DOI:
10.1210/jc.2013-4388. PMID:
24670084. PMCID:
PMC4079315.
106. Li W, Luo S, Smith HT, Tse F. Troubleshooting non-specific binding (NSB) of analyte in a quantitative LC-MS/MS urine assay. In : Presented at ASMS 2008; Denver. p. Poster WPR 385.
107. Lame ME, Chambers EE, Blatnik M. 2011; Quantitation of amyloid beta peptides Aβ(1-38), Aβ(1-40), and Aβ(1-42) in human cerebrospinal fluid by ultra-performance liquid chromatography-tandem mass spectrometry. Anal Biochem. 419:133–9. DOI:
10.1016/j.ab.2011.08.010. PMID:
21888888.
110. Clinical and Laboratory Standards Institute. 2012. Evaluation of detection capability for clinical laboratory measurement procedures. CLSI guideline EP17-A2. 2nd ed. Clinical and Laboratory Standards Institute;Wayne, PA:
111. Hoofnagle AN, Becker JO, Wener MH, Heinecke JW. 2008; Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry. Clin Chem. 54:1796–804. DOI:
10.1373/clinchem.2008.109652. PMID:
18801935. PMCID:
PMC2739673.
112. Clarke NJ, Zhang Y, Reitz RE. 2012; A novel mass spectrometry-based assay for the accurate measurement of thyroglobulin from patient samples containing antithyroglobulin autoantibodies. J Investig Med. 60:1157–63. DOI:
10.2310/JIM.0b013e318276deb4. PMID:
23138009.
113. Kushnir MM, Rockwood AL, Roberts WL, Abraham D, Hoofnagle AN, Meikle AW. 2013; Measurement of thyroglobulin by liquid chromatography-tandem mass spectrometry in serum and plasma in the presence of antithyroglobulin autoantibodies. Clin Chem. 59:982–90. DOI:
10.1373/clinchem.2012.195594. PMID:
23396140. PMCID:
PMC4016991.
114. Shuford CM, Johnson JS, Thompson JW, Holland PL, Hoofnagle AN, Grant RP. 2020; More sensitivity is always better: measuring sub-clinical levels of serum thyroglobulin on a μLC-MS/MS system. Clin Mass Spectrom. 15:29–35. DOI:
10.1016/j.clinms.2020.01.001.
115. Shiraishi S, Lee PW, Leung A, Goh VH, Swerdloff RS, Wang C. 2008; Simultaneous measurement of serum testosterone and dihydrotestosterone by liquid chromatography-tandem mass spectrometry. Clin Chem. 54:1855–63. DOI:
10.1373/clinchem.2008.103846. PMID:
18801940.
116. Kushnir MM, Rockwood AL, Roberts WL, Pattison EG, Bunker AM, Fitzgerald RL, et al. 2006; Performance characteristics of a novel tandem mass spectrometry assay for serum testosterone. Clin Chem. 52:120–8. DOI:
10.1373/clinchem.2005.052167. PMID:
16299050.
117. Pauwels S, Antonio L, Jans I, Lintermans A, Neven P, Claessens F, et al. 2013; Sensitive routine liquid chromatography-tandem mass spectrometry method for serum estradiol and estrone without derivatization. Anal Bioanal Chem. 405:8569–77. DOI:
10.1007/s00216-013-7259-5. PMID:
23892882.
118. Kushnir MM, Rockwood AL, Bergquist J, Varshavsky M, Roberts WL, Yue B, et al. 2008; High-sensitivity tandem mass spectrometry assay for serum estrone and estradiol. Am J Clin Pathol. 129:530–9. DOI:
10.1309/LC03BHQ5XJPJYEKG. PMID:
18343779.
119. Maunsell ZO, Wright DJ, Rainbow SJ. 2005; Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem. 51:1683–90. DOI:
10.1373/clinchem.2005.052936. PMID:
16020493.
120. Shah I, James R, Barker J, Petroczi A, Naughton DP. 2011; Misleading measures in Vitamin D analysis: a novel LC-MS/MS assay to account for epimers and isobars. Nutr J. 10:46. DOI:
10.1186/1475-2891-10-46. PMID:
21569549. PMCID:
PMC3114718.
121. Wang S, Magill JE, Vicente FB. 2005; A fast and simple high-performance liquid chromatography/mass spectrometry method for simultaneous measurement of whole blood tacrolimus and sirolimus. Arch Pathol Lab Med. 129:661–5. DOI:
10.5858/2005-129-0661-AFASHL. PMID:
15859639.
122. Seger C, Tentschert K, Stöggl W, Griesmacher A, Ramsay SL. 2009; A rapid HPLC-MS/MS method for the simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human blood samples. Nat Protoc. 4:526–34. DOI:
10.1038/nprot.2009.25. PMID:
19325549.
123. Koster RA, Dijkers EC, Uges DR. 2009; Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood. Ther Drug Monit. 31:116–25. DOI:
10.1097/FTD.0b013e318192304c. PMID:
19065123.
124. Adam BW, Hall EM, Sternberg M, Lim TH, Flores SR, O'Brien S, et al. 2011; The stability of markers in dried-blood spots for recommended newborn screening disorders in the United States. Clin Biochem. 44:1445–50. DOI:
10.1016/j.clinbiochem.2011.09.010. PMID:
21963384. PMCID:
PMC4557772.
125. Anderson G, Scott M. 1991; Determination of product shelf life and activation energy for five drugs of abuse. Clin Chem. 37:398–402. DOI:
10.1093/clinchem/37.3.398. PMID:
2004447.
126. Kerns EH, Di L, Testa B. Accelerated stability profiling in drug discovery. Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies. In : Lipophilicity Symposium, 3rd; Feb 2006; Zurich, Switzerland. p. 281–306. DOI:
10.1002/9783906390468.ch17.
128. Fink HA, Ewing SK, Ensrud KE, Barrett-Connor E, Taylor BC, Cauley JA, et al. 2006; Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. J Clin Endocrinol Metab. 91:3908–15. DOI:
10.1210/jc.2006-0173. PMID:
16849417.
130. Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, et al. 2010; Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 363:123–35. DOI:
10.1056/NEJMoa0911101. PMID:
20554979.
131. Sharma A, Kapoor E, Singh RJ, Chang AY, Erickson D. 2018; Diagnostic thresholds for androgen-producing tumors or pathologic hyperandrogenism in women by use of total testosterone concentrations measured by liquid chromatography-tandem mass spectrometry. Clin Chem. 64:1636–45. DOI:
10.1373/clinchem.2018.290825. PMID:
30068692.
132. Trost LW, Mulhall JP. 2016; Challenges in testosterone measurement, data interpretation, and methodological appraisal of interventional trials. J Sex Med. 13:1029–46. DOI:
10.1016/j.jsxm.2016.04.068. PMID:
27209182. PMCID:
PMC5516925.
133. Substance Abuse and Mental Health Services Administration, HHS. 2008; Mandatory Guidelines for Federal Workplace Drug Testing Programs. Federal Register. 73:71858–907. DOI:
10.1016/j.forsciint.2007.03.008. PMID:
17434274.
134. De Jesús VR, Mei JV, Cordovado SK, Cuthbert CD. 2015; The newborn screening quality assurance program at the centers for disease control and prevention: thirty-five year experience assuring newborn screening laboratory quality. Int J Neonatal Screen. 1:13–26. DOI:
10.3390/ijns1010013. PMID:
26309908. PMCID:
PMC4545740.
135. Trufelli H, Palma P, Famiglini G, Cappiello A. 2011; An overview of matrix effects in liquid chromatography-mass spectrometry. Mass Spectrom Rev. 30:491–509. DOI:
10.1002/mas.20298. PMID:
21500246.
136. Schuhmacher J, Zimmer D, Tesche F, Pickard V. 2003; Matrix effects during analysis of plasma samples by electrospray and atmospheric pressure chemical ionization mass spectrometry: practical approaches to their elimination. Rapid Commun Mass Spectrom. 17:1950–7. DOI:
10.1002/rcm.1139. PMID:
12913858.
137. Ismaiel OA, Zhang T, Jenkins RG, Karnes HT. 2010; Investigation of endogenous blood plasma phospholipids, cholesterol and glycerides that contribute to matrix effects in bioanalysis by liquid chromatography/mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 878:3303–16. DOI:
10.1016/j.jchromb.2010.10.012. PMID:
21056019.
138. Cappiello A, Famiglini G, Palma P, Pierini E, Termopoli V, Trufelli H. 2008; Overcoming matrix effects in liquid chromatography-mass spectrometry. Anal Chem. 80:9343–8. DOI:
10.1021/ac8018312. PMID:
19551950.
139. Baduel C, Mueller JF, Tsai H, Gomez Ramos MJ. 2015; Development of sample extraction and clean-up strategies for target and non-target analysis of environmental contaminants in biological matrices. J Chromatogr A. 1426:33–47. DOI:
10.1016/j.chroma.2015.11.040. PMID:
26643725.
140. Carmical J, Brown S. 2016; The impact of phospholipids and phospholipid removal on bioanalytical method performance. Biomed Chromatogr. 30:710–20. DOI:
10.1002/bmc.3686. PMID:
26773720.
141. Choi BK, Hercules DM, Gusev AI. 2001; Effect of liquid chromatography separation of complex matrices on liquid chromatography-tandem mass spectrometry signal suppression. J Chromatogr A. 907:337–42. DOI:
10.1016/S0021-9673(00)01052-9. PMID:
11217041.
142. Gritti F, Guiochon G. 2005; Critical contribution of nonlinear chromatography to the understanding of retention mechanism in reversed-phase liquid chromatography. J Chromatogr A. 1099:1–42. DOI:
10.1016/j.chroma.2005.09.082. PMID:
16271269.
143. Ouakhssase A, Chahid A, Choubbane H, Aitmazirt A, Addi EA. 2019; Optimization and validation of a liquid chromatography/tandem mass spectrometry (LC-MS/MS) method for the determination of aflatoxins in maize. Heliyon. 5:e01565. DOI:
10.1016/j.heliyon.2019.e01565. PMID:
31193078. PMCID:
PMC6515151.
144. Goeury K, Vo Duy S, Munoz G, Prévost M, Sauvé S. 2019; Data supporting the optimization of liquid chromatography tandem mass spectrometry conditions to analyze EPA-priority hormones and bisphenol A in water samples. Data Brief. 24:103958. DOI:
10.1016/j.dib.2019.103958. PMID:
31193341. PMCID:
PMC6526397.
145. Bheemanapally K, Ibrahim MMH, Briski KP. 2020; Ultra-high-performance liquid chromatography-electrospray ionization-mass spectrometry for high-neuroanatomical resolution quantification of brain estradiol concentrations. J Pharm Biomed Anal. 191:113606. DOI:
10.1016/j.jpba.2020.113606. PMID:
32966939. PMCID:
PMC7581564.
146. Davies NH, Euerby MR, McCalley DV. 2006; Study of overload for basic compounds in reversed-phase high performance liquid chromatography as a function of mobile phase pH. J Chromatogr A. 1119:11–9. DOI:
10.1016/j.chroma.2005.11.096. PMID:
16386747.
147. Riter LS, Vitek O, Gooding KM, Hodge BD, Julian RK Jr. 2005; Statistical design of experiments as a tool in mass spectrometry. J Mass Spectrom. 40:565–79. DOI:
10.1002/jms.871. PMID:
15880604.
148. Moreiras G, Leão JM, Gago‐Martínez A. 2018; Design of experiments for the optimization of electrospray ionization in the LC‐MS/MS analysis of ciguatoxins. J Mass Spectrom. 53:1059–69. DOI:
10.1002/jms.4281. PMID:
30109731.
149. Lickteig A, Salske M, Rappold B. Design of optimization: how to improve performance of high-volume clinical LC/MS/MS assays. In : Presented at ASMS 2015; St. Louis. p. Poster MP16.